A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2
about
Misdelivery at the Nuclear Pore Complex-Stopping a Virus Dead in Its TracksEvolutionary Analyses Suggest a Function of MxB Immunity Proteins Beyond Lentivirus RestrictionRestriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization SignalOligomerization Requirements for MX2-Mediated Suppression of HIV-1 InfectionAccumulation of MxB/Mx2-resistant HIV-1 Capsid Variants During Expansion of the HIV-1 Epidemic in Human PopulationsMxB Is Not Responsible for the Blocking of HIV-1 Infection Observed in Alpha Interferon-Treated Cells.Mx oligomer: a novel capsid pattern sensor?Capsid-Dependent Host Factors in HIV-1 Infection.Effects of Inner Nuclear Membrane Proteins SUN1/UNC-84A and SUN2/UNC-84B on the Early Steps of HIV-1 Infection.Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.MxB is an interferon-induced restriction factor of human herpesviruses.Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein
P2860
Q26801484-A621D25A-6D94-4B4D-97DD-9BAA3C1928A3Q28551681-BF31D5D2-930C-4D00-8385-7711AFEB7331Q35914350-FE2A4461-1F87-46A9-BB72-6B0CA8463086Q36433874-77D4E99F-D508-4F4F-BE70-3D1AFBB7EAEDQ37034818-D18D91A9-2F14-49CF-A0E8-91B45DC5DE25Q38807646-228C72BB-7333-46E0-984B-6EC59CE70396Q38834397-B0B998EE-E45F-446C-B0F8-1858116B2ECDQ39320682-C662EAD1-97B6-4C74-A642-62DC46EFF9B1Q40107041-69454815-17B5-433C-A87B-EAF734EAA365Q47146547-E06AF331-5C6B-4BCD-BBDC-55EC0A5FE022Q52576485-DD7C9620-8A03-4668-A879-7D8C26AC4FDBQ54207401-B77B62D2-A4E9-4FC3-8050-B78599254CEDQ56530177-357E9028-D944-4277-AE0E-ADD540FC0579Q58693128-E97805F4-F8F0-45FE-94A5-237770055D7D
P2860
A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A triple-arginine motif in the ...... HIV-1 inhibition by human MX2
@ast
A triple-arginine motif in the ...... HIV-1 inhibition by human MX2
@en
type
label
A triple-arginine motif in the ...... HIV-1 inhibition by human MX2
@ast
A triple-arginine motif in the ...... HIV-1 inhibition by human MX2
@en
prefLabel
A triple-arginine motif in the ...... HIV-1 inhibition by human MX2
@ast
A triple-arginine motif in the ...... HIV-1 inhibition by human MX2
@en
P2093
P2860
P356
P1433
P1476
A triple-arginine motif in the ...... HIV-1 inhibition by human MX2
@en
P2093
Caroline Goujon
Rebecca A Greenbury
Stelios Papaioannou
Tomas Doyle
P2860
P304
P356
10.1128/JVI.00169-15
P407
P577
2015-02-11T00:00:00Z